HIM
PBYI icon

Hillsdale Investment Management’s Puma Biotechnology PBYI Stock Holding History

Hillsdale Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-77,800
Closed -$413K – 734
2025
Q3 		$413K Sell
77,800
-7,000
-8% -$29.7K 0.01% 436
2025
Q2 		$291K Buy
+84,800
New +$271K 0.01% 436
2023
Q4 		– Sell
-27,276
Closed -$71.7K – 624
2023
Q3 		$71.7K Sell
27,276
-775,627
-97% -$2.64M 0.01% 412
2023
Q2 		$2.83M Sell
802,903
-31,200
-4% -$97.3K 0.26% 145
2023
Q1 		$2.58M Buy
834,103
+167,897
+25% +$633K 0.22% 142
2022
Q4 		$2.82M Buy
+666,206
New +$2.3M 0.24% 142

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $19.9B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return